Search GLEAM-DB / CoGenEx-PM3
Advanced search and filters
Input query
Recognized gene
PAH
Normalized c.HGVS
c.*19G>T, c.1002C>T, c.1003A>G, c.1004A>C, c.1010G>T and 44 more
Normalized p.HGVS
p.(=), p.(Arg413Cys), p.(Arg413Gly), p.(Arg53His), p.(Asp129Val) and 33 more
Matching records
340
PM3-positive records
47
Results are ordered by PM3-relevant evidence first. Reviewed source only indicates whether main text, supplementary material, or both were reviewed; it is not the evidence conclusion.
| Gene | Variant | Evidence | PM3 context | Publication | Reviewed source | Actions |
|---|---|---|---|---|---|---|
| PAH |
NM_000277.3:c.158G>A
|
Phase-confirmed PM3 evidence
High confidence
|
Confirmed in trans with c.728G > A
context: Confirmed in trans
|
36333673
Mild hyperphenylalaninemia (hpa) presenting as orthostatic tremor: a case report.
BMC neurology, 2022
|
Main article | |
| PAH |
NM_000277.3:c.158G>A
|
Phase-unconfirmed biallelic evidence
High confidence
|
Possible compound heterozygous with c.728G>A; p.R243Q
context: Compound heterozygous candidate
|
41413260
Newborn screening for inherited metabolic disorders in central China: a retrospective study of 153,956 infants using non-derivatized tandem mass spectrometry.
Scientific reports, 2025
|
Main article | |
| PAH |
NM_000277.3:c.158G>A
|
Phase-unconfirmed biallelic evidence
High confidence
|
Possible compound heterozygous with c.721C>T; c.728G>A; p.Arg241Cys; +1 more
context: Compound heterozygous candidate
|
41357791
Incidence and disease spectrum of inherited metabolic diseases screened by tandem mass spectrometry in Huai'an from 2018 to 2024.
Frontiers in pediatrics, 2025
|
Main article | |
| PAH |
NM_000277.3:c.158G>A
|
Phase-unconfirmed biallelic evidence
High confidence
|
Possible compound heterozygous with c.60+4A>G; p.?; splicing
context: Compound heterozygous candidate
|
41291872
The incidence rate and gene mutation characteristics of hyperphenylalaninemia in Yunnan Province, Southwest China.
Orphanet journal of rare diseases, 2025
|
Main article | |
| PAH |
NM_000277.3:c.158G>A
|
Phase-unconfirmed biallelic evidence
High confidence
|
Possible compound heterozygous with c.631C>A; p.Pro211Thr
context: Compound heterozygous candidate
|
40293582
Genotypic and phenotypic characteristics of Turkish patients with phenylalanine metabolism disorders.
Metabolic brain disease, 2025
|
Main article | |
| PAH |
NM_000277.3:c.158G>A
|
Phase-unconfirmed biallelic evidence
High confidence
|
Possible compound heterozygous with c.688G > A
context: Compound heterozygous candidate
|
39969324
Exploring a novel model for newborn genetic screening in Ningxia, northern China: A retrospective observational study.
Medicine, 2024
|
Main article | |
| PAH |
NM_000277.3:c.158G>A
|
Phase-unconfirmed biallelic evidence
High confidence
|
Possible compound heterozygous with c.547G>T; c.611A>G; c.728G>A; +5 more
context: Compound heterozygous candidate
|
39776477
Application of targeted high-throughput sequencing as a diagnostic tool for neonatal genetic metabolic diseases following tandem mass spectrometry screening.
Frontiers in public health, 2024
|
Supplementary material | |
| PAH |
NM_000277.3:c.158G>A
|
Phase-unconfirmed biallelic evidence
High confidence
|
Possible compound heterozygous with c.1238G>C; c.526C>T; c.688G>A; +13 more
context: Compound heterozygous candidate
|
39670100
Spectrum analysis of inborn errors of metabolism for expanded newborn screening in Xinjiang, China.
PeerJ, 2024
|
Supplementary material | |
| PAH |
NM_000277.3:c.158G>A
|
Phase-unconfirmed biallelic evidence
High confidence
|
Possible compound heterozygous with c.1315+6T>A
context: Compound heterozygous candidate
|
38577637
The significance of machine learning in neonatal screening for inherited metabolic diseases.
Frontiers in pediatrics, 2024
|
Main article | |
| PAH |
NM_000277.3:c.158G>A
|
Phase-unconfirmed biallelic evidence
High confidence
|
Potential PM3 evidence identified; genotype context not structured
context: Compound heterozygous candidate
|
38105703
Analysis of gene variation and long-term follow-up in children with phenylalanine hydroxylase deficiency diagnosed by newborn screening.
Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2023
|
Main article | |
| PAH |
NM_000277.3:c.158G>A
|
Phase-unconfirmed biallelic evidence
High confidence
|
Possible compound heterozygous with c.1199+502A>T
context: Compound heterozygous candidate
|
37237386
Identification of deep intronic variants of PAH in phenylketonuria using full-length gene sequencing.
Orphanet journal of rare diseases, 2023
|
Main article | |
| PAH |
NM_000277.3:c.158G>A
|
Phase-unconfirmed biallelic evidence
High confidence
|
Homozygous for query variant
context: Homozygous evidence
|
37098607
The spectrum of phenylalanine hydroxylase variants and genotype-phenotype correlation in phenylketonuria patients in Gansu, China.
Human genomics, 2023
|
Main article | |
| PAH |
NM_000277.3:c.158G>A
|
Phase-unconfirmed biallelic evidence
High confidence
|
Potential PM3 evidence identified; genotype context not structured
context: Compound heterozygous candidate
|
37004080
Allelic phenotype prediction of phenylketonuria based on the machine learning method.
Human genomics, 2023
|
Main article | |
| PAH |
NM_000277.3:c.740G>A
|
Phase-unconfirmed biallelic evidence
Low confidence
|
Possible compound heterozygous with c.611A>G; c.728G>A
context: Compound heterozygous candidate
|
37004080
Allelic phenotype prediction of phenylketonuria based on the machine learning method.
Human genomics, 2023
|
Supplementary material | |
| PAH |
NM_000277.3:c.158G>A
|
Phase-unconfirmed biallelic evidence
High confidence
|
Homozygous for query variant
context: Homozygous evidence
|
36927542
A retrospective analysis of MS/MS screening for IEM in high-risk areas.
BMC medical genomics, 2023
|
Main article | |
| PAH |
NM_000277.3:c.158G>A
|
Phase-unconfirmed biallelic evidence
High confidence
|
Homozygous for query variant
context: Homozygous evidence
|
36246604
Expanded newborn screening for inherited metabolic disorders by tandem mass spectrometry in a northern Chinese population.
Frontiers in genetics, 2022
|
Main article | |
| PAH |
NM_000277.3:c.158G>A
|
Phase-unconfirmed biallelic evidence
High confidence
|
Possible compound heterozygous with c.1073 T > G; c.1138del; c.1162G > A; +21 more
context: Compound heterozygous candidate
|
36104584
Characterization of phenylalanine hydroxylase gene variants and analysis of genotype-phenotype correlation in patients with phenylalanine hydroxylase deficiency from Fujian Province, Southeastern China.
Molecular biology reports, 2022
|
Main article | |
| PAH |
NM_000277.3:c.60G>C
|
Phase-unconfirmed biallelic evidence
High confidence
|
Possible compound heterozygous with c.158G > A; Arg53His
context: Compound heterozygous candidate
|
36104584
Characterization of phenylalanine hydroxylase gene variants and analysis of genotype-phenotype correlation in patients with phenylalanine hydroxylase deficiency from Fujian Province, Southeastern China.
Molecular biology reports, 2022
|
Main article | |
| PAH |
NM_000277.3:c.158G>A
|
Phase-unconfirmed biallelic evidence
High confidence
|
Possible compound heterozygous with c.1199 + 502A > T; c.842 + 2 T > A; exon1 and upstream deletion
context: Compound heterozygous candidate
|
35869558
Identification of phenylketonuria patient genotypes using single-gene full-length sequencing.
Human genomics, 2022
|
Main article | |
| PAH |
NM_000277.3:c.158G>A
|
Phase-unconfirmed biallelic evidence
High confidence
|
Possible compound heterozygous with c.208_210del
context: Compound heterozygous candidate
|
35664874
Application of the Artificial Intelligence Algorithm Model for Screening of Inborn Errors of Metabolism.
Frontiers in pediatrics, 2022
|
Supplementary material | |